Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study

R. Chapple, Christopher; Arañó, Pedro; Bosch, Jackie; De Ridder, Dirk; E. J. L. Kramer, A.; Ridder, Arwin

doi:10.1111/j.1464-410x.2004.04561.x

Public

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study

Published in British Journal of Urology • Dec 17, 2003

Authors:

Christopher R. Chapple

Pedro Arañó

Jackie Bosch

Abstract

OBJECTIVES: To evaluate the dose-response relationship and safety/tolerability of solifenacin succinate (YM905) in the treatment of overactive bladder (OAB), and to compare its efficacy and safety/tolerability with tolterodine 2 mg twice daily. PATIENTS AND METHODS: This multicentre study included a...

Subject

Tolterodine

Solifenacin

Tolerability

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!